IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $215,576 | -4.6% | 4,753 | -6.7% | 0.01% | -33.3% |
| Q3 2022 | $226,000 | -80.5% | 5,095 | -83.7% | 0.01% | -79.7% |
| Q2 2022 | $1,158,000 | +573.3% | 31,284 | +574.2% | 0.06% | +742.9% |
| Q1 2022 | $172,000 | +2050.0% | 4,640 | +2521.5% | 0.01% | +133.3% |
| Q3 2020 | $8,000 | -97.3% | 177 | -96.5% | 0.00% | -88.9% |
| Q2 2020 | $301,000 | -18.9% | 5,101 | -35.0% | 0.03% | -30.8% |
| Q1 2020 | $371,000 | -32.4% | 7,850 | -13.7% | 0.04% | -7.1% |
| Q4 2019 | $549,000 | +15.1% | 9,094 | +14.2% | 0.04% | -14.3% |
| Q3 2019 | $477,000 | – | 7,960 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |